美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Lion Biotechnologies Inc.

6.95

-0.2000-2.80%

成交量：50.22萬

成交額：349.03萬

市值：4.32億

市盈率：-3.93

高：7.20

開：7.20

低：6.80

收：7.15

52周最高：9.58

52周最低：4.90

股本：6,220.10萬

流通股本：1,696.51萬

量比：- -

換手率：2.96%

股息：- -

股息率：- -

每股收益(TTM):-1.7700

淨資產收益率：--

總資產收益率：--

市淨率：2.41

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Lion Biotechnologies Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.lionbio.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Lion Biotechnologies, Inc. 是一家新興的生物技術公司，專註於培養細胞，使用自體腫瘤浸潤淋巴細胞（TIL）治療轉移性黑色素瘤等實體瘤的細胞治療方法的發展和商業化。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LBIO/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBIO\",,,,,undefined,":{"symbol":"LBIO","market":"US","secType":"STK","nameCN":"Lion Biotechnologies Inc.","latestPrice":6.95,"timestamp":1498593600000,"preClose":7.15,"halted":4,"volume":502207,"delay":0,"floatShares":16965116,"shares":62201000,"eps":-1.77,"marketStatus":"退市","change":-0.2,"latestTime":"06-27 16:00:00 EDT","open":7.2,"high":7.2,"low":6.8,"amount":3490338.65,"amplitude":0.055944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.77,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1754899200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":7.15,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBIO\",,,,,undefined,":{"symbol":"LBIO","floatShares":16965116,"roa":"--","roe":"--","lyrEps":0,"shares":62201000,"dividePrice":0,"high":7.2,"amplitude":0.055944,"preClose":7.15,"low":6.8,"week52Low":4.9,"pbRate":"2.41","week52High":9.58,"institutionHeld":0,"latestPrice":6.95,"eps":-1.77,"divideRate":0,"volume":502207,"delay":0,"ttmEps":-1.77,"open":7.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBIO\",params:#limit:5,,,undefined,":[{"date":"2017-06-28","symbol":"LBIO","newSymbol":"IOVA","type":"symbolChange","dateTimestamp":1498622400000},{"market":"US","date":"2017-05-01","symbol":"LBIO","fiscalQuarterEnding":null,"expectedEps":-0.28,"name":null,"time":"盤後","type":"earning","dateTimestamp":1493611200000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2017-03-07","symbol":"LBIO","fiscalQuarterEnding":null,"expectedEps":-0.26,"name":null,"time":"盤後","type":"earning","dateTimestamp":1488862800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2016-11-04","symbol":"LBIO","fiscalQuarterEnding":null,"expectedEps":-0.19,"name":null,"time":"盤前","type":"earning","dateTimestamp":1478232000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2016-05-09","symbol":"LBIO","fiscalQuarterEnding":null,"expectedEps":-0.14,"name":null,"time":"","type":"earning","dateTimestamp":1462766400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBIO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.lionbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.021},{"period":"3month","weight":0.1291},{"period":"6month","weight":0.0606},{"period":"1year","weight":0.2008},{"period":"ytd","weight":0.0872}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Lion Biotechnologies, Inc. 是一家新興的生物技術公司，專註於培養細胞，使用自體腫瘤浸潤淋巴細胞（TIL）治療轉移性黑色素瘤等實體瘤的細胞治療方法的發展和商業化。","exchange":"NASDAQ","name":"Lion Biotechnologies Inc.","nameEN":"Lion Biotechnologies"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LBIO\",market:\"US\",,,undefined,":null}}